News

For years, a mysterious tangle of tissue lurking beneath the ovary has been dismissed, absent from anatomy charts and medical ...
Knowing the anatomy of the inside and outside of a vagina ... The inside cavity of the genitals has many parts. The two ovaries store a person’s eggs and are the primary reproductive organs.
Asia FX weak with Chinese yuan down; dollar hits 3-yr low amid brief tariff relief By Investing.com - Apr 14, 2025 Investing.com-- Most Asian currencies weakened on Monday, with the Chinese yuan ...
The human digestive system refers to the organs that take in food and break them down. Digestion describes the complex process that enables the nutrients in food to enter the body and its cells ...
If you are having fertility treatment, fluid in the cul-de-sac can be a symptom of ovarian hyperstimulation syndrome (OHSS)—a condition where high doses of fertility hormones make your ovaries swell.
Monthly real gross domestic product (GDP) is estimated to have grown by 0.5% in February 2025, with growths in all main sectors, following January 2025 which showed no growth (revised up from a fall ...
Dr. Callie Torres was portrayed by Sara Ramirez, who left the American medical drama series Grey’s Anatomy in the season 12 finale after 10 years in the show. Television critics gave Ramirez's ...
The humerus is your upper arm bone. It is the longest bone in the upper part of your body and is connected to many important tendons and ligaments. The top of the humerus is part of the shoulder joint ...
The show we can't seem to let go of. Whipple procedures, dancing it out, McSteamy and McDreamy… Grey’s Anatomy has been the comforting (and at times stress-inducing, heartbreaking and tense) constant ...
Legendary investor Bill Gross, the "Bond King" behind $270 billion funds at PIMCO, thus has a blunt warning for those looking to scoop up supposed bargains during market tumult. "I think it's a ...
BRASILIA, April 8 (Reuters) - Brazil's public sector gross debt rose in February from the previous month, central bank data showed on Tuesday, driven by the country's heavy interest burden.
BELLA is a single-arm, open-label trial with a planned enrollment of 90 women with recurrent, platinum-resistant ovarian cancer at approximately 50 sites in North America, Europe and Asia-Pacific.